Antimicrobial Use and Resistance in Australia Surveillance System

AURA

The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System was established, and continues to be operated, by the AURA National Coordination Unit (NCU) at the Commission. The system captures data on antimicrobial use and antimicrobial resistance in human health. 

Antimicrobial resistance (AMR) poses one of the most important risks to our health today. AMR occurs when an organism develops resistance to an antimicrobial that is used to treat it.

Antimicrobials are an integral component of health care delivery and they need to be readily available and effective. When resistance emerges and the effectiveness is reduced it has a significant impact on an individual’s treatment and the community more broadly.  

In 2015, the Australian Government Department of Health released the First National Antimicrobial Resistance Strategy to combat the threat of AMR across human health, animal health and agriculture. Surveillance of AMR and antimicrobial use is a key objective of the strategy, and a fundamental requirement for effective action to address AMR in Australia.

The Australian Government Department of Health and the states and territories provide funding to the Commission for development and coordination the Antimicrobial Use and Resistance in Australia (AURA) Surveillance System, through the AURA National Coordination Unit.  AURA is vital to Australia’s efforts to prevent and contain AMR in human health as it provides information needed to understand where and when specific threats emerge, as well as guiding efforts to mitigate the risk of AMR at the local, jurisdictional and national levels.